Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitten is a line of injectable mesotherapy solutions developed by JETEMA Co., Ltd. for aesthetic and dermatological applications. The primary active ingredient in the Vitten collection is hyaluronic acid, which is utilized to provide deep dermal hydration and stimulate collagen production. The product line includes Vitten Hydro, containing non-cross-linked hyaluronic acid (15 mg/mL), and Vitten Hydro Plus, containing semi-cross-linked hyaluronic acid (15 mg/mL). These solutions are administered via intradermal injection to deliver hydration and nutrients directly to the skin, targeting concerns such as wrinkles, fine lines, dryness, and loss of elasticity. Additionally, the line includes Vitten Hair Rx, a formulation specifically designed for hair restoration. The biological mechanism focuses on restoring the skin barrier and providing significant moisture retention (reportedly 200-300 times normal levels).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitten.